NG Bio
NG Bio Ltd is an early-stage investor and venture builder focused on extending health span by addressing immune responses that contribute to major human diseases. The company collaborates with pharmaceutical companies and co-investors to enhance its investments in the life sciences sector.
- Venture building
- Investment advisory
- Therapeutic development
Locations
Digital Popularity
Social Media
Competitors
InMotion Ventures is a venture capital firm that invests in exceptional entrepreneurs, focusing on early-stage businesses from Seed to Series B.
24Haymarket focuses on growth equity and venture capital investments in the UK, investing aligned private capital to accelerate commercial success.
Adequita Capital is a private investment firm regulated by the Financial Conduct Authority (FCA) of the United Kingdom, specialising in private equity and venture building.
Station12 is dedicated to helping build the next generation of businesses in the sectors of sport, entertainment, and knowledge.
Company Details
NG Bio is operated by NG Bio Ltd and is a Active company incorporated on 16 July 2020 with the registered office located in London, Greater London. NG Bio Ltd was registered 5 years ago.
Status
Active
Size
Micro
Directors
2
Age
5 years old
Employees
4
Turnover
Unreported
Total Assets
£426.51K
Cash in Bank
£7.06K
Total Liabilities
-£1.45M